Osteoporosis Clinical Trials

Showing 301-320 of 595 trials

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

NCT02155595

The purpose of this protocol is to determine the risk of atypical femoral shaft (thigh bone) fractures after long term fracture prevention therapy with a class of drugs called "bisphosphonates", colloquially referred to as Alendronate, risedronate, Ibandronate, and Zoledronate. In addition, the study is designed to find out which patient is most likely to develop this potential life changing complication and why. Finally, the results of this study will help clinicians to better understand the reason and thus tailor patient specific treatments…i.e., "the right treatment for the right patient for right duration."

OsteoporosisAtypical Femoral FracturesProdromal Bone Deterioration

Henry Ford Health System738 participantsStarted May 2014

Detroit, Michigan, United States

COMPLETEDPhase 2

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

NCT01992159

The purpose of this study is to determine if treatment with romosozumab increases bone mineral density in Japanese women with postmenopausal osteoporosis.

Postmenopausal Osteoporosis (PMO)

Amgen252 participantsStarted Oct 2012

Anjyo-shi, Aichi-ken, Japan • Fukuoka, Fukuoka, Japan • Kitakyushu-shi, Fukuoka, Japan +24 more locations

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Related Searches

Oklahoma Native American Women's Osteoporosis Screening Study

Study on the microRNA Expression Level in Postmenopausal Osteoporosis

BREAST CANCER AND EXERCISE

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism

Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index

Partnership for Applied Research in Fracture Prevention Programs for the Elderly

Normative Database for HR-pQCT-Based Radius and Tibia Strength

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

General Practitioner's Place in the Treatment of Fracture Osteoporosis in the Elderly

Texture Analysis for Postmenopausal Osteoporosis

Cohort Study: Perceptual Urge Sensation

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016

A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066)